Clinical Trials Directory

Trials / Sponsors / Evolus, Inc.

Evolus, Inc.

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingNon Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Glabellar Frown Lines
—2023-03-15
CompletedStudy to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar L
Glabellar Frown Lines
Phase 22022-03-30
CompletedSafety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006
Glabellar Frown Lines
Phase 22015-05-01
CompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
Glabellar Frown Lines
Phase 32015-01-01
CompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
Glabellar Frown Lines
Phase 32015-01-01
CompletedSafety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
Glabellar Frown Lines
Phase 22014-08-01